Home Topics Psoriasis<\/p>\n
The Adolescent Psoriasis Quality of Life (APso-QOL) instrument represents the first age-appropriate and disease-specific health-related quality of life (HRQOL) instrument for use in adolescents with psoriasis, according to study data published in the British Journal of Dermatology.<\/p>\n
Researchers used a combination of qualitative and quantitative methods to develop and establish the preliminary validity of the APso-QOL instrument. They gathered qualitative data concerning HRQOL in adolescents with psoriasis from 18 adolescents (aged 12-17 years), 14 parents, and 4 healthcare professionals and combined them with cognitive interview testing (n=12) to result in a 41-item draft version. After item reduction, the final APso-QOL was a 17-item instrument consisting of 2 subscales showing good fit to their respective Rasch models: Psychosocial Impact (APso-PI; 12 items) and the impact of Physical Symptoms and Treatment (APso-PST; 5 items; n=50). Using state-of-the-art methods, the researchers found the APso-QOL to be psychometrically sound and good preliminary support for construct validity. In addition, they found the test-retest reliability of this instrument to be good. Because of their nonuniform nature, the 2 subscales should ideally be scored separately, the team noted; however using a combined summary score may be justified for the APso-QOL, similar to other instruments of comparable structure.<\/p>\n
The investigators concluded that, The APso-QOL is intended for use in daily clinical practice to support dermatologists and other health care professionals in providing optimal care for adolescents with psoriasis.<\/p>\n
Disclosure: Several study authors declared affiliations with the pharmaceutical industry. Please see the original reference for a full list of authors disclosures.<\/p>\n
Follow @DermAdvisor<\/p>\n
References<\/p>\n
Randa H, Khoury LR, Grnborg TK, Lomholt JJ, Skov L, Zachariae R. Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument (APso-QOL): a disease-specific measure of quality of life in adolescents with psoriasis [published online November 19, 2019]. Br J Dermatol. doi:10.1111\/bjd.18719<\/p>\n
Please login or register first to view this content.<\/p>\n
LoginRegister<\/p>\n
Next post in PsoriasisClose<\/p>\n
<\/p>\n
See the original post here: Home Topics Psoriasis The Adolescent Psoriasis Quality of Life (APso-QOL) instrument represents the first age-appropriate and disease-specific health-related quality of life (HRQOL) instrument for use in adolescents with psoriasis, according to study data published in the British Journal of Dermatology. Continue reading
\nPreliminary Validation of the Adolescent Psoriasis Quality of Life Instrument - Dermatology Advisor<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"